# RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine

> **NCT02122744** · NA · WITHDRAWN · sponsor: **University of Liege**

## Conditions studied

- Chronic Migraine

## Interventions

- **DEVICE:** Super Rapid Magstim Stimulator
- **DEVICE:** Super Rapid Magstim Stimulator (sham)

## Key facts

- **NCT ID:** NCT02122744
- **Lead sponsor:** University of Liege
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02122744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02122744, "RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02122744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*